Evidence map›Paper›PMID 37131894›Full record

ArticleReports of biochemistry & molecular biology2023

EBNA1 Upregulates P53-Inhibiting Genes in Burkitt's Lymphoma Cell Line.

Seyed Mohammad Ali Hashemi, Abdolvahab Moradi, Seyed Younes Hosseini, Hadi Razavi Nikoo, Taravat Bamdad, Mahboobeh Razmkhah, Jamal Sarvari, Alijan Tabarraei

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Reports of biochemistry & molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Seyed Mohammad Ali HashemiDepartment of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Abdolvahab MoradiDepartment of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Seyed Younes HosseiniDepartment of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Hadi Razavi NikooDepartment of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Taravat BamdadDepartment of Virology, School of Medical Sciences, Tarbiat Modarres University, Tehran, Iran.
Mahboobeh RazmkhahShiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Jamal SarvariDepartment of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Alijan TabarraeiInfectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Shiraz University of Medical Sciences · IRGolestan University · IRGolestan University of Medical Sciences · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Suppression of p53 is an important mechanism in Epstein-Barr virus associate-tumors and described as EBNA1-USP7 which is a key axis in p53 suppression. Thus, in this study, we aimed to evaluate the function of EBNA1 on the expression of p53-inhibiting genes including Methods: The electroporation method was used to transfect the BL28 cell line with Results: Conclusion: It seems that EBNA1 could strongly upregulate p53-inhibiting genes including

Indexed as

EBNA1Epstein-Barr virusP53P53-inhibiting GenesUSP7

Identifiers

PMID37131894
PMCPMC10149133
OpenAlexW4367593224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.